Literature DB >> 21781072

Chromoblastomycosis: a clinical and molecular study of 18 cases in Rio de Janeiro, Brazil.

Marcelle de F Mouchalouat1, Maria Clara Gutierrez Galhardo, Rosely Maria Zancopé-Oliveira, Paulo Cezar Monteiro Fialho, Janice Mery C de Oliveira Coelho, Patrícia Morais Silva Tavares, Antonio Carlos Francesconi do Valle.   

Abstract

BACKGROUND: Chromoblastomycosis (CBM) is a chronic subcutaneous mycosis caused by dematiaceous fungi.
METHODS: We described epidemiological data, clinical presentation, and treatment of 18 cases of CBM diagnosed in Rio de Janeiro, Brazil. Diagnosis was obtained by mycological, histopathological findings demonstrating typical muriform cells with confirmation of isolated by DNA sequencing of the ribosomal internal transcribed spacer.
RESULTS: The majority of patients were male (72.2%) ranging from 39 to 83 years old, farm laborers and construction workers. The duration of disease varied from four months to 32 years. The most common presentations were verrucous form in ten (55.6%) patients, followed by tumoral in three (16.7%) patients, primarily of moderate (55.6%) and severe (38.9%) intensity. Lower (44.4%) and upper limbs (33.3%) were the most affected sites. Fonsecaea pedrosoi isolated from 14 (77.8%), and Cladophialophora carrionii isolated from one case (5.6%). Fifteen patients (83.3%) were treated. Six patients (40%) received oral itraconazole 200-400 mg/day, five patients (33.3%) received oral itraconazole 200-400 mg/day combined with fluconazole 200 mg/day, and four (26.7%) patients were submitted to surgery. The duration of therapy varied from 12 to 48 months. Cure rate was 80% (12/15). No relapse was observed after two years of follow-up.
CONCLUSIONS: Success was due to attending a center with specialized clinical care, laboratory support, and pharmaceutical care.
© 2011 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21781072     DOI: 10.1111/j.1365-4632.2010.04729.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  12 in total

1.  New Molecular Markers Distinguishing Fonsecaea Agents of Chromoblastomycosis.

Authors:  Gabriela X Schneider; Renata R Gomes; Amanda Bombassaro; Kassiely Zamarchi; Morgana F Voidaleski; Flávia F Costa; Aniele C R Leão; Bruna J F S Lima; Bruna S Soley; Israella R Colombo; Giovanna Z Cândido; Mohammad J Najafzadeh; Jiufeng Sun; Conceição M P S de Azevedo; Sirlei G Marques; G Sybren de Hoog; Vânia A Vicente
Journal:  Mycopathologia       Date:  2019-07-17       Impact factor: 2.574

2.  Clinical and demographic profile of chromoblastomycosis in a referral service in the midwest of São Paulo state (Brazil).

Authors:  Gabriela Franco Marques; Paula Yoshiko Masuda; Juliana Martins Prazeres Sousa; Jaison Antônio Barreto; Patrick Alexander Wachholz
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

3.  Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.

Authors:  Huan Tan; Yan Xu; Xue-Mei Lan; Ya-Guang Wu; Cun-Jian Zhou; Xi-Chuan Yang
Journal:  Mycopathologia       Date:  2015-01-10       Impact factor: 2.574

4.  Accuracy of direct examination and culture as compared to the anatomopathological examination for the diagnosis of chromoblastomycosis: a systematic review.

Authors:  Jules Rimet Borges; Bárbara Álvares Salum Ximenes; Flávia Tandaya Grandi Miranda; Giordana Bruna Moreira Peres; Isabella Toscano Hayasaki; Luiz César de Camargo Ferro; Mayra Ianhez; Marco Tulio Antonio Garcia-Zapata
Journal:  An Bras Dermatol       Date:  2022-05-25       Impact factor: 2.113

5.  Chromoblastomycosis: tissue modifications during itraconazole treatment.

Authors:  Kátia Sheylla Malta Purim; Murilo Calvo Peretti; José Fillus; Marcia Olandoski
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

6.  Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge.

Authors:  Felipe Maurício Soeiro Sampaio; Maria Clara Gutierrez Galhardo; Leonardo Pereira Quintella; Paulo Roberto Cotrim de Souza; Janice Mary Chicarino de Oliveira Coelho; Antonio Carlos Francesconi do Valle
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

Review 7.  Molecular Diagnosis of Two Major Implantation Mycoses: Chromoblastomycosis and Sporotrichosis.

Authors:  Danièle Maubon; Cécile Garnaud; Lala Soavina Ramarozatovo; Rapelanoro Rabenja Fahafahantsoa; Muriel Cornet; Tahinamandranto Rasamoelina
Journal:  J Fungi (Basel)       Date:  2022-04-09

8.  Chromoblastomycosis: Report of two cases on face from urban industrial area.

Authors:  Narayanan K Panicker; Shirish S Chandanwale; Yugal K Sharma; Urmi S Chaudhari; Gunjan V Mehta
Journal:  Indian Dermatol Online J       Date:  2013-10

9.  Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil.

Authors:  Felipe Maurício Soeiro Sampaio; Bodo Wanke; Dayvison Francis Saraiva Freitas; Janice Mery Chicarino de Oliveira Coelho; Maria Clara Gutierrez Galhardo; Marcelo Rosandiski Lyra; Maria Cristina da Silva Lourenço; Rodrigo de Almeida Paes; Antonio Carlos Francesconi do Valle
Journal:  PLoS Negl Trop Dis       Date:  2017-02-13

10.  Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.

Authors:  Rowena Alves Coelho; Fábio Brito-Santos; Maria Helena Galdino Figueiredo-Carvalho; Juliana Vitoria Dos Santos Silva; Maria Clara Gutierrez-Galhardo; Antonio Carlos Francesconi do Valle; Rosely Maria Zancopé-Oliveira; Luciana Trilles; Wieland Meyer; Dayvison Francis Saraiva Freitas; Rodrigo Almeida-Paes
Journal:  PLoS Negl Trop Dis       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.